Gutwerg Ori 4

What Happened
Ori Gutwerg, Senior Vice President, Generics at ANI Pharmaceuticals (ANIP), reported the sale of 2,772 shares on May 12, 2026. The shares were disposed in an open-market sale at $79.50 per share for a total value of $220,374. This was a sale (not a purchase); sales by insiders can be routine and do not by themselves indicate a change in company outlook.

Key Details

• Transaction date: 2026-05-12; reported on Form 4 filed 2026-05-13 (Accession 0001846478-26-000013).
• Price and amount: 2,772 shares sold at $79.50 each; total proceeds $220,374.
• Shares owned after transaction: Not specified in the provided excerpt of the filing — check the full Form 4 for post-transaction holdings.
• Footnotes / plan: No 10b5-1 plan, tax withholding, or other special footnotes were indicated in the provided transaction detail.
• Timeliness: Filing appears timely (reported the next day); no late-filing flag noted in the provided data.

Context

• This was a straightforward open-market sale (transaction code S). Sales by executives can be for many personal reasons; they are not, by themselves, a definitive signal about company prospects.
• If you track insider activity, give more weight to ongoing patterns (multiple buys or sells over time) or large purchases, since single sales are common. Check the complete Form 4 for total holdings and any additional disclosures.